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OBJECTIVES The purposes of the present study were to: 1) determine whether fibrinogen (Fg) is the plasma
protein responsible for spontaneous echo contrast (SEC), and 2) investigate modulators of
SEC.
BACKGROUND Spontaneous echo contrast has been linked to the development of thromboemboli. The blood
products and their interaction responsible for SEC formation have not been fully elucidated.
METHODS Blood echogenicity was examined with the use of quantitative videodensitometry over a
controlled range of flow velocities in an in vitro model. Human blood samples were analyzed
in a manner to methodically eliminate individual blood components from whole blood to
determine which components are responsible for the formation of SEC.
RESULTS The videodensity (VD) of whole blood was found to be flow-dependent, with higher VD at
lower flow rates, and correlated with visually dense SEC. The following blood products
produced faint VD values: washed red blood cells (wRBCs), platelet-depleted plasma, Fg,
defibrinated plasma, wRBCs plus defibrinated plasma, and physiologic saline. The VD of
wRBCs increased incrementally as increasing concentrations of Fg were added. At each
hematocrit (Hct) range, as Fg concentration increased, the SEC became denser, and the VD
level also increased until a plateau level was reached that was distinct for each Hct. The
addition of sialic acid, which inhibits RBC-RBC aggregation, decreased the amount of SEC,
even in the presence of Fg.
CONCLUSIONS These results demonstrated that Fg-mediated RBC aggregation may be responsible for SEC
generation. Furthermore, a unique stoichiometric relationship exists between Fg and RBC
concentrations that is necessary for blood echogenicity. (J Am Coll Cardiol 2003;41:
603–10) © 2003 by the American College of Cardiology Foundation
Spontaneous echo contrast (SEC), or “smoke,” is a swirling
gray haze of variable density detected by transthoracic or
transesophageal ultrasound imaging of the chambers of the
heart and great vessels under conditions of low flow (1).
Spontaneous echo contrast has been linked to the develop-
ment of thromboemboli in low-flow clinical states such as
mitral stenosis, atrial fibrillation, cardiomyopathy, and left
ventricular aneurysm (2–5). However, whether SEC itself
contributes directly to thrombus formation or is just a
marker of a prothrombotic milieu is unclear.
Numerous investigators have sought a better understand-
ing of the mechanism responsible for SEC formation
(6–12). Our previous study documented that SEC is de-
pendent on red blood cell (RBC) and plasma protein
interactions (9). Several reports have postulated that fibrin-
ogen (Fg), given its major role in RBC aggregation, would
be a likely contributor to SEC formation (12–18). However,
these studies were performed in vitro at ambient tempera-
ture, therefore providing no direct evidence of this sug-
gested effect at body temperature. Thus, we sought to
determine the components of SEC under diverse condi-
tions, including human body temperature.
Therefore, the purposes of the present study were to: 1)
determine whether Fg is the plasma protein responsible for
SEC, and 2) investigate the modulators of SEC density.
METHODS
Subjects. Ten healthy human male and female volunteers
(age range, 25 to 45 years) served as donors of blood
products, after providing written informed consent for an
institutional review board approved study protocol. Each
volunteer may have donated blood on more than one
occasion. Blood samples were all anticoagulated with hep-
arin (5 U/ml). For each experiment multiple study samples
were prepared from single blood donations (90 ml) from
each volunteer. A total of 90 blood samples were examined.
The study was approved by the institutional review board.
In vitro models. Blood samples were analyzed in two
different in vitro models: 1) a large cylindric continuous flow
chamber (30-mm diameter) in which blood was circulated
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at varying shear rates from a small tube (3.8-mm diameter)
(Figs. 1A and 2), in a 3-ml mixing chamber (Fig. 1B)
CONTINUOUS FLOW CHAMBER. Blood (90 ml) was circu-
lated by a peristaltic pump through a narrow (3.8-mm
diameter) plastic tube into a larger cylindric expansion
chamber (30-mm diameter) at different velocities at body
temperature (37°C). A linear 7.5-MHz phased array, 128-
element transducer (Acuson, Mountain View, California)
was applied longitudinally to the chamber and fixed in
position (Fig. 1A). The video images were recorded on a
one-half inch VHS recorder and analyzed by two indepen-
dent observers. Videodensity (VD) was assigned using a
commercially available video-densitometry analyzer (Nova
Microsonics, New Jersey) based on a relative scale of 0 to
100 (0 black, 100 white). Videodensity was analyzed in
three 1-cm2 regions of interest in the inlet of the larger
chamber: 1 cm distal to inlet port at the center, and 1 cm
both superior and inferior to the central inflow jet. Video-
density was measured at different velocity rates (0 to 150
ml/min) in the center of the flow and in the periphery of the
chamber at the three fixed locations.
MIXING CHAMBER. To evaluate the echodensity of a larger
number of blood product combinations at both stasis and
under shear forces, we designed an apparatus for smaller
blood volumes that would facilitate temperature control
(Fig. 1B). This design required a sample of only 2.5 ml of
blood, which was placed into a 3-ml cylindrical syringe
containing a small teflon-coated stirring magnet (3  6
mm2) at its bottom. The blood was applied via a side-arm
device, and the syringe was then sealed with a plastic cap.
To obtain echo images free of reverberations, the syringe
was placed horizontally in a 60-ml water bath at room and
body temperature, and fixed in position over a magnetic
stirrer adjusted to stir the syringe at varying rates of
agitation. The echo transducer was applied longitudinally to
the chamber and fixed in position with a C-arm device. Two
independent observers using the same video densitometry
analyzer used for the larger flow chamber analyzed the
recorded video images. The region of interest analyzed was
a 1-cm2 cross-section obtained 1 cm above the agitation
produced by the magnetic stirrer. Imaging was performed at
varying rates of magnetic stirring and then continuously for
6 min after the stirring was stopped.
Echocardiographic standardizations. The same echo ul-
trasound power transmission was used for all imaging. After
testing multiple combinations of machine settings, the
following were considered to be the optimal for imaging of
SEC in both the flow and mixing chambers: 1) gray scale, 2)
log compression  40 dB, and 3) gain  20 dB.
To calibrate the two measuring systems (the flow cham-
ber and mixing chamber), video densitometry measure-
ments for the normal heparinized whole blood (hematocrit
[Hct]  44% and Fg  320 mg/dl) were obtained at stasis.
The VD value of images obtained at stasis from the flow
chamber (VD  69.2) was less than the value obtained by
imaging the mixing chamber in the water bath (VD 
78.0). Spontaneous echo contrast was subjectively defined as
visible swirling haze or smoke-like echo signals and was
measured objectively by VD at stasis.
Study of blood components. The effect of blood compo-
nents on SEC formation was studied by using a systematic
deletion of components from whole blood. This allowed us
to observe the interactions of different components of blood
and, thereby, determine which promote SEC formation.
We first utilized the continuous, large volume flow chamber
to analyze which blood products alone or in combination
produced SEC. Subsequently, we verified these results using
the small mixing chamber, enabling evaluation of a large
quantity of samples using a smaller, more manageable
volume of blood. Shown in Table 1 are the blood compo-





RBC  red blood cell
SEC  spontaneous echo contrast
VD  videodensity
WBC  white blood cell
wRBC  washed red blood cell
Figure 1. Pictoral representation of the flow chamber (A) and mixing
chamber (B).
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Whole blood, defined as RBCs, white blood cells
(WBCs), plasma Fg, and platelets (plt) were utilized ini-
tially. The concentrations of the whole blood components
were as follows: Hct  42% to 46%, WBCs  6.9 
103/l, plts 200 to 350 103/l, and plasma Fg levels
175 to 300 mg/dl.
Washed red blood cells (wRBC) were obtained by cen-
trifuging whole blood at 1,800 g at room temperature for
15 min. The plasma and buffy coat were discarded, and the
RBC were resuspended in physiological saline to obtain the
desired Hct ranges. Because of difficulty in reproducing
exact Hct concentrations, four ranges were used: very low (7
to 14), low (27 to 35), medium (39 to 47), and high (53 to
65).
Platelet poor plasma was obtained by centrifuging whole
blood at 800 g at room temperature for 10 min. The
supernatant plt-rich plasma and the buffy coat were trans-
ferred to another tube and recentrifuged at 1,800 g at room
temperature for 10 min to obtain a plt-poor plasma super-
natant (plt  20 to 40 103/l).
Defibrinated blood was obtained by centrifuging whole
blood at 1,800 g for 10 min at room temperature, and the
plasma was separated. Defibrinating snake venom enzyme,
Ancrod (Sigma, St. Louis, Missouri: Agkistrodon rhodos-
toma venom, Malayan Pit Viper) was added to a final
concentration of 1 U/dl. The Ancrod and plasma were first
incubated at 37°C for 20 min and then placed at 20°C for
10 min to slow down the reaction rate. The mixture was
then centrifuged at 1,800 g for 5 min at room temperature.
The supernatant and defibrinated plasma had no detectable
clottable Fg (Diagnostica Stago St 4: American Bioproducts
Company, Parsippany, New Jersey). The defibrinated
plasma had no detectable, residual ancrod activity as judged
by its inability to defibrinate a sample of Fg (40 mg/dl
before incubation and 38 mg/dl after incubation).
Lyophilized human Fg (Sigma, 90% clottable) was dis-
Figure 2. Spontaneous echo contrast videodensity over time using blood (hematocrit  44%) with varying fibrinogen levels.
Table 1. Contents of Various Blood Components
Components RBC Fibrinogen WBC Platelets Serum
Whole blood     
Washed RBCs     
Platelet-poor plasma     
Reconstituted blood     
Fibrinogen     
Defibrinated plasma     
Defibrinated blood     
Normal saline     
RBC  red blood cell; WBC  white blood cell.
605JACC Vol. 41, No. 4, 2003 Rastegar et al.
February 19, 2003:603–10 SEC Videodensity
solved in deionized water to obtain the desired concentra-
tions (38, 60, 170, 240, and 331 mg/dl).
Reconstituted blood was obtained by adding Fg (in
increments to achieve concentrations of 38, 60, 170, 240,
and 331 mg/dl) to a mixture of defibrinated plasma and
wRBCs.
Lastly, defibrinated “blood” was obtained by adding
wRBCs to defibrinated plasma.
Normal saline (0.9%) served as our protein-free control.
These blood products (anticoagulated with heparin
5 U/ml) and control solution were all evaluated in the
continuous flow chamber at differing flow rates (stasis,
25 ml/min, 50 ml/min, 60 ml/min, 75 ml/min, and
125 ml/min).
Given that SEC was produced only when combining
RBCs and Fg in the continuous chamber, we were able to
focus on the RBC-Fg interaction in the mixing chamber.
Fibrinogen and plts alone served as controls for this part of
the study. To determine the dependence of SEC on
RBC-RBC interaction, sialic acid, an agent that opposes
RBC interaction by contributing to the electrorepulsive
forces on the RBC surface, was added to the reconstituted
mixture of washed red cells (Hct 42%) Fg (493 mg/dl).
Sialic acid (Sigma) was prepared to final concentrations of
4 mM and 40 mM by dissolving it in normal saline.
Each of the above blood samples was analyzed for the
following: Hct, WBC, and plt counts, and Fg concentra-
tion, both before and after echo imaging.
Photomicrographs of SEC. To evaluate the role of RBC
aggregates in SEC formation, 100 l samples of wRBCs 
Fg were slowly taken from the syringe 6 min after stasis had
been established and placed on a glass microscope slide. The
slides were viewed using 10 oculars and a 40 phase
contrast objective (Nikon, Melville, New York) by two
independent observers blinded to the Hct and Fg levels.
Each observer scored the RBC aggregation as “none,” “low,”
or “high,” and photomicrographs were taken with a (Nikon)
camera.
The interobserver correlation for VD measurements for
63 separate video images assessed by two reviewers was
excellent (r  0.99).
RESULTS
The large flow chamber was utilized as an attempt to
reproduce in vivo interactions between various blood com-
ponents. Saline served as our cell- and protein-free control,
and produced a VD value of zero at all flow rates. We then
evaluated the blood components systematically—
individually and in combination—as described in the
Methods section. As shown in Table 2, the VD is directly
related to an interaction between RBCs and Fg. For
example, whole blood, which contains all blood compo-
nents, has high VD values compared with isolated Fg,
RBCs, plt-poor plasma, or defibrinated plasma. Further-
more, its VD is higher at stasis (VD  69) compared with
flow rates of 125 ml/min (VD  12.9). In contrast, the VD
of lone Fg is equal to 9.4, and that of wRBCs, plt-poor
plasma, and defibrinated plasma is 30, 35, and 31, respec-
tively.
To test the dependence of VD level on Fg, Fg was added
to wRBCs and defibrinated plasma. As Fg was incremen-
tally added to the wRBC/defibrinated plasma mixture, the
VD increased from faint (in the absence of Fg) to a VD of
96 when the Fg concentration reached 330 mg/dl. As with
whole blood, the VD diminished with increasing shear rates
(characterized by higher velocities). The VD of reconsti-
tuted blood was also evaluated as a function of time. As
previously stated, the VD decreases with increasing flow.
When flow is abruptly terminated (time  0), SEC ap-
peared throughout the chamber. As time elapsed, SEC
became denser and eventually reached a plateau (Fig. 2). It
appears that the higher the Fg concentration, the longer it
took for the VD to reach the plateau.
Importantly, these results were reproducible in the mixing
chamber, thereby enabling us to readily test a large number
of samples in a more manageable in vitro system. As in the
larger continuous chamber, Fg solution was echo-free at
stasis and at all flow rates with a VD  9.2 (Table 2). The
interdependency of Hct and Fg levels was substantiated by
analyzing a larger number of blood samples with different
Hct and Fg concentrations. The results are as follows:
1. At the very low Hct range (7% to 14%), no SEC was
detected for Fg concentrations below 300 mg/dl. As the
Fg concentration increased to 1,800 mg/dl, the VD
gradually increased, reaching a plateau at Fg concentra-
tions 2,000 mg/dl (Fig. 3A).
2. At the low Hct group (27% to 35%), VD increased
rapidly as Fg concentration was increased from 100 to
200 mg/dl. A VD plateau was reached at 300 to
400 mg/dl of Fg concentration (Fig. 3B).







Physiologic saline 0 0
Fg (700 mg/dl) 9.4 9.2
wRBC 30.0 34.0
Platelet poor plasma 35.0
Whole blood 69.0 78.0
Defib plasma 31.0
Defib plasma  wRBC 31.0
Defib plasma  wRBC  Fg
(330 mg/dl)
96.0
wRBC (Hct  42)  Fg
(493 mg/dl)
86.0
wRBC (Hct  42)  Fg (490 mg/dl 
sialic acid) (4 mmol)
64.0
(40 mmol) 34.0
*Studies conducted at stasis.
Defib  defibrinated; Fg  fibrinogen; Hct  hematocrit; wRBC  washed red
blood cells.
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Figure 3. Blood spontaneous echo contrast videodensity as a function of increasing fibrinogen levels for different hematocrit concentrations. (A) Videodensity value versus fibrinogen concentration for the
hematocrit range 7% to 14%. (B) Videodensity value versus fibrinogen concentration for the hematocrit range 27% to 35%. (C) Videodensity value versus fibrinogen concentration for the hematocrit range











3. At the physiologic range of Hct (39% to 47%), the major
increase in VD occurred at Fg concentration between
400 to 500 mg/dl (Fig. 3C).
4. For the high Hct group (53% to 65%), SEC was
achieved at Fg level of 250 mg/dl, and reached a VD
plateau at 600 mg/dl (Fig. 3D).
By analyzing the VD by concentration of Fg graph for
each set of Hct concentrations, we noted a specific stoichi-
ometric relationship between Fg concentration and RBC
interaction to generate SEC.
The addition of plts (580  103/l) to a mixture of
wRBCs (Hct  27%) and Fg (621 mg/dl) increased VD
from 65 to 85 at stasis.
Lastly, the addition of sialic acid to wRBCs and Fg was
analyzed. The VD values of the wRBCs and Fg (Hct 
42% and Fg  490 mg/dl yielded a VD  86) decreased as
sialic acid was added (sialic acid concentration of 4 mM
yielded a VD  64; sialic acid concentration of 40 mM
yielded a VD  43). The decrease in VD suggested that
sialic acid may prevent SEC formation by increasing the
negative electrorepulsive charges.
The use of microscopic evaluation further supported the
findings of RBC-Fg interdependence on SEC formation.
The photomicrographs (Figs. 4A to 4C) demonstrated that
RBCs alone formed minimal aggregates with a VD value of
24.0 (Fig. 4A). However, RBC aggregation (rouleaux for-
mation) and VD increased as the Fg concentration in-
creased (Fg  349 to 493 mg/dl), in concert with an
increase in the VD value (VD  50 and 59, respectively)
(Figs. 4B and 4C).
DISCUSSION
Previous work from our group had established that RBCs
and plasma protein components, and not plts, were respon-
sible for SEC formation. We carried out this study to
investigate the plasma component responsible for SEC
generation. A previous in vitro study done at ambient
temperature by Fatkin et al. (12) demonstrated that a
protein-mediated red cell aggregation is the mechanism of
SEC in human blood, and suggested that red cells and Fg
were required for blood echogenicity. Our study, which
quantified SEC using in vitro VD measurements of human
blood at body temperature, confirms that SEC is dependent
on the interaction between RBCs and Fg, and their flow
rates. We have also demonstrated that Fg is the principal
plasma protein determinant of SEC generation by eliminat-
ing the echogenicity of whole blood by defibrination and
generating SEC by adding Fg to wRBCs. In contrast to
Fatkin et al. (8), we demonstrated the complex interaction
between RBCs and Fg by titrating increasing Fg concen-
trations to fixed RBC concentration, as well as titrating
increasing RBC concentrations to fixed Fg levels. Further-
more, we have found a stochiometric relationship between
Fg and red cells in SEC formation, such that, at lower Hct
ranges, a higher concentration of Fg is required before SEC
is observed, while the reverse is true at higher Hct ranges.
This suggests an important relationship between the num-
ber of RBCs and Fg molecules. Lastly, we demonstrated
that, with the addition of sialic acid, an agent that opposes
RBC aggregation, SEC is inhibited, strengthening the
argument that greater red cell “clumping” leads to greater
levels of SEC.
Figure 4. (A) Photomicrograph of red blood cell aggregates: washed red
blood cells (hematocrit  58%) and fibrinogen  166 mg/dl. The
videodensity was 24.0. (B) Photomicrograph of red blood cell aggregates:
washed red blood cells (hematocrit  58%) and fibrinogen 349  mg/dl.
The videodensity was 50.0. (C) Photomicrograph of red blood cell
aggregates: washed red blood cells (hematocrit  58%) and fibrinogen 
493 mg/dl. The videodensity was 59.0.
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Importance of SEC. Spontaneous echo contrast has been
implicated as a marker of an inflammatory state preceding
blood clot formation and subsequent embolic events. It is
utilized as a determinant of risk when evaluating patients
with such conditions as atrial fibrillation, dilated left atria in
mitral stenosis, or in dilated cardiomyopathic ventricles or
large apical aneurysms (18–23). Independent studies have
demonstrated that stroke or other embolic event rates are
higher in patients with SEC compared with patients with-
out SEC (19,24). Furthermore, patients with SEC also have
significantly reduced survival (p  0.025) compared with
those without SEC (19). Prospective studies evaluating the
changes in SEC fail to demonstrate the resolution of SEC
in the presence of antithrombotic therapy (20). This raises
the question of the determinants of SEC as well as potential
treatments, given SECs strong association with adverse
thromboembolic events.
Determinants of SEC. Several clinical studies have sug-
gested a variety of etiologies involved in the generation of
SEC. Blood factors such as Fg, RBCs, plts, and leukocytes,
as well as the interaction between these components, have
all been implicated in SEC formation (6,7).
In addition, structural properties of the heart and great
vessels have been correlated with SEC formation. For
example, dilated left atria, cardiomyopathic ventricles, and
dilated aortic segments are all independently associated with
SEC formation (18,21–23,25). Furthermore, SEC has also
been correlated to the flow velocity of blood (26,27).
Regions characterized by low-flow, which correspond to low
shear rates, have been correlated with increased formation of
SEC. This is especially true of blood flow patterns in the left
atrial appendage (3,28). In the present study, the RBC-Fg
interaction was responsible for the generation of SEC, and
that the quantity of SEC (as measured by VD) varied by
RBC and Fg concentration, as well as on the velocity of
their flow.
Quantification of SEC. We utilized videodensitometry to
objectively grade the severity and to quantify the amount of
SEC. We had a significant interobserver agreement for
quantifying SEC videodensitometry. Videointensity has
been previously validated as a reliable and rapid tool to
quantify SEC (29). Recent studies have reported on other
techniques to quantify SEC (30,31).
Relationship of SEC to thrombus formation. Though
multiple groups have attempted to characterize the deter-
minants of SEC, the relationship between SEC to actual
thrombus formation has not been fully elucidated (5).
Though SEC is plt-independent, plts contribute to throm-
bus, and may be necessary for clinical clot formation.
Clinically, SEC can be imaged in cardiac chambers of
patients even if they are anticoagulated with heparin or
warfarin. Blood used in our preparations were anticoagu-
lated, which prevented clotting but did not interfere with
SEC formation. It is notable, however, that Fg not only
promotes SEC, but is also able to support plt aggregation by
binding to the plt glycoprotein IIb/IIIa receptor complex
(32). It has also been shown that plt membrane activation
markers are expressed in the embolic and pre-embolic states
of patients with nonrheumatic atrial fibrillation. A more
recent study, which examined blood from patients with and
without SEC, found a higher activation and aggregation of
plts and plt-leukocyte aggregates in venous than arterial
blood, as well as in the left atrial chamber compared with
the right atrial chamber in patients with mitral stenosis (33).
This implies a higher level of plt activity of blood in the
venous system or in generally low-flow states and may
support a role for plt aggregates in the pathogenesis of SEC
(34). Our study, however, has demonstrated that plts are not
necessary nor are they directly related to SEC formation,
which is substantiated by prior studies (5). Interestingly, our
study demonstrated that Fg concentrations in the range of
400 to 500 mg/dl were associated with the greatest SEC
generation in the Hct range from 39% to 47%. Those
clinical studies demonstrated similar levels of Fg in patients
presenting with acute coronary syndromes (35,36).
Study limitations. We have demonstrated that SEC for-
mation is dependent on RBC interactions with Fg. How-
ever, the VD value of whole blood with the same Hct and
Fg concentration (175 to 350 mg/dl) is higher than what
was obtained by reconstituting wRBCs with Fg. The most
likely reason for this is that other plasma properties also
contribute to SEC formation.
Differences in VD between the flow chamber and the
small mixing chamber may have been due to several factors.
The larger flow chamber utilized 90 ml of blood compared
with only 3 ml in the small syringe. Thus, ultrasound
attenuation due to larger volume and distance to sample
volume may have affected the VD measurements, with
higher values for similar solutions measured in the smaller
chamber. The smaller chamber may have facilitated more
uniform mixing compared with the larger chamber in which
a narrow jet entering a large static volume may generate
eddy currents of flow.
Conclusions. In summary, we have demonstrated that Fg
can affect RBC rouleaux formation in a flow-dependent,
plt-independent phenomenon and is detectable by ultra-
sound as SEC. The observation that Fg concentration
required to achieve maximal VD varied with the Hct
concentration suggested an important relationship between
RBCs and Fg in producing SEC. Future treatments aimed
at preventing protein-RBC interactions as demonstrated by
direct RBC-Fg interactions in our study, or even RBC-
RBC interactions, may provide alternatives to anticoagulant
and antiplatelet therapy to reduce cardiac thromboembolic
risk.
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